Finance

Beta
Lists
500420:BOM
Torrent Pharmaceuticals Ltd
₹4,330.00
-0.90%
(-39.50) 1D
Jun 4, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 500420...
Open
₹4,327.05
High
₹4,423.00
Low
₹4,327.05
Mkt. cap
1.47T
Avg. vol.
16.78K
Volume
16.94K
Dividend
0.88%
Quarterly dividend
₹9.50
Ex-dividend date
May 29, 2026
P/E ratio
67.74
52-wk high
₹4,714.50
52-wk low
₹3,109.10
EPS
₹63.92
Shares outstanding
170.00M
No. of employees
18K
Open
₹4,327.05
High
₹4,423.00
Low
₹4,327.05
Mkt. cap
1.47T
Avg. vol.
16.78K
Volume
16.94K
Dividend
0.88%
Quarterly dividend
₹9.50
Ex-dividend date
May 29, 2026
P/E ratio
67.74
52-wk high
₹4,714.50
52-wk low
₹3,109.10
EPS
₹63.92
Shares outstanding
170.00M
No. of employees
18K
News stories
From sources across the web
Profile
Torrent Pharmaceuticals Ltd, d/b/a Torrent Pharma, is an Indian multinational pharmaceutical company, part of the Torrent Group and headquartered in Ahmedabad. It was promoted by U. N. Mehta, initially as Trinity Laboratories Ltd, and was later renamed Torrent Pharmaceuticals Ltd. Torrent Pharmaceuticals operates in more than 40 countries with over 2,000 product registrations globally. Torrent Pharma is active in the therapeutic areas of cardiovascular, central nervous system, gastro-intestinal, diabetology, anti-infective and pain management segments. It also has a presence in therapeutic segments of nephrology, oncology, gynecology, respiratory and pediatrics. Wikipedia
About Torrent Pharmaceuticals Ltd
CEO-
Employees18.3K
Founded1959
HeadquartersAhmedabad, Gujarat, India
SectorPharmaceutical industry
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
31.78B
33.02B
33.03B
41.97B
Cost of goods sold
7.74B
8.00B
7.99B
10.15B
Cost of revenue
7.74B
8.00B
7.99B
10.15B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.05B
6.27B
6.51B
8.48B
Operating expense
15.73B
16.23B
16.22B
23.34B
Total operating expenses
23.47B
24.23B
24.21B
33.49B
Operating income
8.31B
8.79B
8.82B
8.48B
Other non operating income
-370.00M
-270.00M
-130.00M
794.40M
EBT including unusual items
7.38B
7.91B
8.14B
5.29B
EBT excluding unusual items
7.38B
8.04B
8.24B
5.46B
Income tax expense
1.90B
2.00B
1.79B
1.65B
Effective tax rate
25.75%
25.28%
21.99%
31.18%
Other operating expenses
7.67B
7.92B
7.65B
9.78B
Net income
5.48B
5.91B
6.35B
3.89B
Net profit margin
17.24%
17.90%
19.22%
9.28%
Earnings per share
16.19
17.75
19.00
12.85
Interest and investment income
-
-
-
384.30M
Interest expense
-560.00M
-480.00M
-450.00M
-2.36B
Net interest expenses
-560.00M
-480.00M
-450.00M
-1.97B
Depreciation and amortization charges
2.01B
2.04B
2.06B
5.08B
EBITDA
10.18B
10.82B
10.69B
11.12B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more